Jazz Pharmaceuticals Director Files Form 144 Notice to Sell $857K in Common Stock

Form 144 Analysis: Jazz Pharmaceuticals plc ($JAZZ)

Transaction Summary

Director Heather Ann McSharry submitted a Form 144 notice indicating an intent to sell 3,507 shares of Jazz Pharmaceuticals common stock through E*TRADE Financial Corporation, with an aggregate market value of approximately $857,602.00 (~$244.54 per share).

Key Details

• Securities Acquired: The shares being offered were acquired on August 28, 2026, via restricted stock vesting as compensation directly from the issuer.
• Timing: Notice dated August 31, 2026, with an approximate sale date of August 31, 2026.
• Market Impact: The proposed sale represents a negligible fraction of the company's 64,914,577 outstanding shares (<0.01%), indicating routine liquidity following a recent equity vesting event.